ASBPNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ASBPW
Aspire-Lakewood Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$8.41−0.37 (-4.21%)
Close on Oct 19, 2026
- Market cap
- $8.73M
- P/E (TTM)
- –
- Dividend yield
- –
Aspire-Lakewood statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Aspire-Lakewood | Industry median |
|---|---|---|
| Market Cap | $11.80M | $164.85M |
| Enterprise Value | -$371.63K | $87.06M |
| PS Ratio | 120.78 | 3.60 |
| PB Ratio | 1.00 | 2.03 |
| P/TBV Ratio | 1.00 | 2.31 |
Enterprise value
| Measure | Aspire-Lakewood | Industry median |
|---|---|---|
| EV / Sales | -3.81 | 2.43 |
Income (trailing twelve months)
| Measure | Aspire-Lakewood | Industry median |
|---|---|---|
| Revenue | $97.66K | $57.94M |
| Gross Profit | -$24.45K | $90.47M |
| Operating Income | -$7.32M | -$21.44M |
| Net Income | -$11.05M | -$22.46M |
| EBITDA | -$7.32M | -$16.91M |
Margins
| Measure | Aspire-Lakewood | Industry median |
|---|---|---|
| Gross Margin | -25.0% | 52.3% |
| Operating Margin | -7494.8% | -44.5% |
| Profit Margin | -11314.1% | -39.2% |
| EBITDA Margin | -7494.8% | -31.3% |
Returns
| Measure | Aspire-Lakewood | Industry median |
|---|---|---|
| Return on Equity (ROE) | -1032.1% | -53.1% |
| Return on Assets (ROA) | -152.1% | -41.0% |
| Return on Capital Employed (ROCE) | -61.7% | -37.8% |
Balance sheet
| Measure | Aspire-Lakewood | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $12.17M | $62.42M |
| Net Cash (Debt) | $12.17M | $15.68M |
| Net Cash Per Share | $8.67 | $0.66 |
| Equity (Book Value) | $11.76M | $48.79M |
| Book Value Per Share | $8.38 | $1.36 |
| Tangible Book Value | $11.76M | $23.06M |
| Working Capital | $11.78M | $75.77M |
Financial position
| Measure | Aspire-Lakewood | Industry median |
|---|---|---|
| Current Ratio | 7.99 | 3.30 |
| Quick Ratio | 7.22 | 2.39 |
| Interest Coverage | -0.79 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Aspire-Lakewood | Industry median |
|---|---|---|
| Operating Cash Flow | -$7.19M | -$12.35M |
Efficiency
| Measure | Aspire-Lakewood | Industry median |
|---|---|---|
| Asset Turnover | 0.01 | 0.38 |
| Inventory Turnover | 0.28 | 2.67 |
Dividends and yields
| Measure | Aspire-Lakewood | Industry median |
|---|---|---|
| Earnings Yield | -93.7% | -22.7% |
Shares
| Measure | Aspire-Lakewood | Industry median |
|---|---|---|
| Shares Outstanding | 1,402,560 | 58,179,650 |
| Shares Change (QoQ) | 673.4% | 0.54% |
| Float | 1,382,560 | 49,173,100 |
| Shares Held by Insiders | 1.43% | 11.6% |
Scores
| Measure | Aspire-Lakewood | Industry median |
|---|---|---|
| Altman Z-Score | -0.05 | -0.24 |
| Piotroski F-Score | 3 | 4 |
Calculated by StockData from Aspire-Lakewood's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.